Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artybone
- Development stage
- Unknown
- Lead developer
- Jointherapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Artybone is a nutraceutical food supplement developed by Jointherapeutics designed to support bone health and skeletal integrity. The formulation contains a combination of glucosamine, chondroitin, essential vitamins, minerals, and calcium. These ingredients work together to provide the necessary building blocks for cartilage maintenance and bone mineralization. Glucosamine and chondroitin are key components of the extracellular matrix in joints, while calcium and vitamins are vital for maintaining bone density and preventing degradation. Artybone is intended for use as a dietary supplement to promote overall bone and joint wellness.
- Brand names
- Artybone
Beyond the preview
Go deeper on Artybone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artybone.